These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 24930383)
41. The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study. Duman D; Demirtunc R; Sahin S; Esertas K J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1007-11. PubMed ID: 18163011 [TBL] [Abstract][Full Text] [Related]
42. Effect of probucol on elderly hypercholesterolemic patients in the FAST study. Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215 [TBL] [Abstract][Full Text] [Related]
44. Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins. Sawayama Y; Tatsukawa M; Okada K; Maeda N; Shimizu C; Kikuchi K; Hayashi J Atherosclerosis; 2003 Dec; 171(2):281-5. PubMed ID: 14644398 [TBL] [Abstract][Full Text] [Related]
45. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821 [TBL] [Abstract][Full Text] [Related]
46. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML; N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131 [TBL] [Abstract][Full Text] [Related]
47. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
48. Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin. Tani S; Takahashi A; Nagao K; Hirayama A Heart Vessels; 2015 Nov; 30(6):762-70. PubMed ID: 25062713 [TBL] [Abstract][Full Text] [Related]
49. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362 [TBL] [Abstract][Full Text] [Related]
50. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin. de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721 [TBL] [Abstract][Full Text] [Related]
51. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances]. Brath H; Wascher TC; Kästenbauer T; Toplak H MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754 [TBL] [Abstract][Full Text] [Related]
53. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus. Shimabukuro M; Higa M; Tanaka H; Shimabukuro T; Yamakawa K; Masuzaki H Diabet Med; 2011 Jul; 28(7):856-64. PubMed ID: 21244474 [TBL] [Abstract][Full Text] [Related]
54. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study. Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444 [TBL] [Abstract][Full Text] [Related]
55. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label). Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R; Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878 [TBL] [Abstract][Full Text] [Related]
57. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627 [TBL] [Abstract][Full Text] [Related]
58. Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis. Hu Y; Tong G; Xu W; Pan J; Ryan K; Yang R; Shuldiner AR; Gong DW; Zhu D Diab Vasc Dis Res; 2009 Oct; 6(4):262-8. PubMed ID: 20368220 [TBL] [Abstract][Full Text] [Related]
59. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions. Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821 [TBL] [Abstract][Full Text] [Related]